Armata Pharmaceuticals Inc (ARMP)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $143.94M
Last updated: Nov 17, 2026 at 11:03 AM ET
Armata Pharmaceuticals Inc (ARMP) Stock Forecast
Analysts expect Armata Pharmaceuticals (ARMP) to earn -$1.87 per share in the fiscal year ending Dec 31, 2026, on revenue of $4.25M. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.45.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates fall 35.3%.
- Fiscal year ending Dec 31, 2026
- -$1.87
- EPS consensus, revenue $4.25M
- Fiscal year ending Dec 31, 2027
- -$1.45
- EPS consensus, revenue $2.75M
- Next report
- Mar 17, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.87 | -$2.27 to -$1.46 | 2 | $4.25M | $3.30M to $5.20M | 2 |
| Dec 31, 2027 | -$1.45 | -$2.04 to -$0.85 | 2 | $2.75M | N/A | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.41 | -$0.56 to -$0.24 | 4 | $525300 | N/A | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$3.81.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.87 | -$1.87 | -$2.27 | -$3.81 | -$3.81 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.45 | -$1.45 | -$1.40 | -$1.34 | -$1.34 | N/A |
Frequently Asked Questions About ARMP
What is the ARMP stock forecast?
Consensus analyst estimates put Armata Pharmaceuticals's EPS at -$1.87 for the fiscal year ending Dec 31, 2026, on revenue of $4.25M.
What EPS do analysts expect from ARMP next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.87, with estimates from -$2.27 to -$1.46 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.45, with estimates from -$2.04 to -$0.85 from 2 analysts.
What revenue do analysts expect from Armata Pharmaceuticals next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $4.25M, with estimates from $3.30M to $5.20M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.75M.
How many analysts cover ARMP?
2 analysts estimate EPS for Armata Pharmaceuticals for the fiscal year ending Dec 31, 2026.
ARMP pages: Overview, Earnings, Forecast, Financials, Competitors